Responding to the Call to Meaningfully Assess Institutional Review Board Effectiveness-Reference-Cited by-同舟云学术

Responding to the Call to Meaningfully Assess Institutional Review Board Effectiveness

Published:2023-07-18 Issue:3 Volume:330 Page:221
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Fernandez Lynch Holly¹²,Hurley Elisa A.¹³,Taylor Holly A.¹⁴

Affiliation:

1. The Consortium to Advance Effective Research Ethics Oversight (AEREO), Philadelphia, Pennsylvania

2. Perelman School of Medicine, University of Pennsylvania, Philadelphia

3. Public Responsibility in Medicine and Research (PRIM&R), Boston, Massachusetts

4. Department of Bioethics, NIH Clinical Center, Bethesda, Maryland

Abstract

This Viewpoint discusses the difficult task of creating a stakeholder-driven, evidence-based approach to assessing institutional review board effectiveness beyond regulatory compliance.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2806686/jama_fernandez_lynch_2023_vp_230059_1689628018.14187.pdf

Reference7 articles.

1. “We measure what we can measure”: struggles in defining and evaluating institutional review board quality.;Lynch;Soc Sci Med,2022

2. Institutional review board quality, private equity, and promoting ethical human subjects research.;Lynch;Ann Intern Med,2020

3. Senators Warren, Brown, and Sanders investigate “inherent” conflicts of interest of private equity-owned institutional review boards. Office of Senator Warren. November 19, 2019. Accessed June 16, 2023. https://www.warren.senate.gov/oversight/letters/senators-warren-brown-and-sanders-investigate-inherent-conflicts-of-interest-of-private-equity-owned-institutional-review-boards

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Proposal by the U.S. Food and Drug Administration for Reliance on Single Institutional Review Boards: Proceed Only With Caution;Annals of Internal Medicine;2024-03

2. IRB stipulations and protocol complexity: An opportunity for collaboration to reduce turnaround times;World Journal of Surgery;2023-12-26